We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Children and adults with type 1 diabetes had reductions ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Children aged 5 years and younger using automated ...

Women with type 1 diabetes (T1D) who use a hybrid closed-loop (HCL) insulin delivery system during the first 6 months postpartum show better glycaemic control, with no increase in the risk for ...

Beta Bionics, an MD+DI reader favorite, has secured $100 million in new equity capital through a series D funding round, putting it in prime position to challenge Medtronic and others in the automated ...

Although automated insulin delivery systems have gained traction in type 1 diabetes, further research is needed to determine the feasibility of using such systems for patients with type 2 diabetes.

TORONTO — Clinical trials have shown that many automated insulin delivery (AID) systems are safe and effective for nonpregnant patients with type 1 diabetes (T1D). They are associated with improved ...